Iroko, Laboratorios Saval deal

Iroko granted Laboratorios Saval exclusive rights to develop and commercialize Zorvolex submicron diclofenac in Bolivia, Chile, Ecuador, Paraguay and Peru. Saval will be responsible for obtaining reg...